Back
Day Range
$25.17
$27.13
52-Week Range
$11.51
$29.80
Volume
217,413
50D / 200D Avg
$26.82
/
$23.56
Prev Close
$26.00
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -12.4 | 0.4 |
| P/B | 6.2 | 2.9 |
| ROE % | -41.2 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -120.67M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-41.18%
ROIC-40.68%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
0.00
Current Ratio12.60
Interest Coverage0.00
Valuation
P/E Ratio
-12.44
P/B Ratio6.23
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -134.22M |
| ROE | -41.18% | ROA | -46.06% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -120.67M |
| ROIC | -40.68% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 12.60 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -12.44 | P/B Ratio | 6.23 |
| P/S Ratio | N/A | PEG Ratio | 1.31 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.67B | Enterprise Value | 1.39B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -134.22M | -100.88M | -76.33M | -42.73M | -29.62M |
| EPS (Diluted) | -2.48 | -2.63 | -2.27 | -1.41 | -0.85 |
| Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | -8,436.95 |
| Operating Income | -145.69M | -96.91M | -86.71M | -54.14M | -28.51M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 291.37M | 398.69M | 167.73M | 212.09M | 101.10M |
| Total Liabilities | 23.61M | 14.65M | 18.47M | 7.14M | 5.31M |
| Shareholders' Equity | 267.76M | 384.05M | 149.26M | 204.95M | 95.79M |
| Total Debt | 861,470.0 | 238,905.0 | 436,822.0 | 250,184.0 | 0.0 |
| Cash & Equivalents | 280.73M | 391.23M | 161.84M | 209.35M | 98.63M |
| Current Assets | 289.42M | 397.85M | 166.85M | 211.57M | 100.95M |
| Current Liabilities | 22.97M | 14.60M | 18.22M | 6.99M | 5.31M |